Search
+
    Read. Lead. Succeed. ET Prime - For Members Only
    • Sharp Insight-rich, Indepth stories across 20+ sectors
    • Access the exclusive Economic Times stories, Editorial and Expert opinion

    Coronavirus is making it tough to breathe, even for Indian pharmaceuticals

    Synopsis

    Sun Pharmaceutical Industries’ domestic sales were Rs 2,388 crore in April-June compared with Rs 2,364 crore in the previous quarter. Lupin’s domestic business fell 6% from the same quarter last year.

    MUMBAI: Sales of drugs in India, including anti-infective, respiratory and gastro medicines, fell for the fourth month in a row as the Covid-19 epidemic and lockdowns kept patients from visiting doctors for minor ailments and other treatments, data from the All India Origin Chemists and Druggists Association showed.Since April, sales of anti-infective drugs have dropped by an average of 15% and the declining trend continued in July, with a fall
    • FONT SIZE
    • SAVE
    • PRINT
    • COMMENT
    ET

    Uh-oh! This is an exclusive story available for selected readers only.

    Worry not. You’re just a step away.

    Why ?

    • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

    • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

    • Clean experience with
      Minimal Ads
    • Comment & Engage with ET Prime community
    • Exclusive invites to Virtual Events with Industry Leaders
    • A trusted team of Journalists & Analysts who can best filter signal from noise
    • ​Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-​

    The Economic Times